|
|
|
To establish lean and effective infrastructure for global clinical
development and pharmacovigilance according to customers needs and requirements
|
|
|
|
|
To design and implement (!) smart and effective global clinical development
programs and agree these with relevant regulatory authorities,
key opinion leaders and other stakeholders
|
|
|
|
|
To focus on value creating milestones like clinical proof-of-concept
(POC) or pivotal trials
|
|
|
|
|
To optimize clinical data packages for outlicensing, further
financing or registration
|
|
|
|
|
With assessment of clinical development programs (e.g. clinical
due diligence)
|
